Condition: Chemotherapy Induced Alopecia · Sponsor: Luminate Medical, Inc.
The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemotherapy, when hair preservation is a Grade ≤1 graded by an independent healthcare professional on the Common Terminology Criteria for Adverse Events (CTCAE)? * What is the subject incidence of Grade 1 or above Adverse Device Events (ADE's)?
This description comes directly from the study's public registry record.
Kimberly Wilkinson · +1 (713) 855-3775 · kimberly.wilkinson@luminatemed.com
Always discuss trial participation with your own doctor first.
| Inspira Health - Mullica Hills | Mullica Hill, New Jersey, United States | Recruiting |
| Inspire Health - Vineland | Vineland, New Jersey, United States | Recruiting |
| Guthrie - Our Lady of Lourdes Memorial Hospital | Binghamton, New York, United States | Recruiting |
| Clinical Research Alliance | Westbury, New York, United States | Recruiting |
| Guthrie Sayer Medical Centre | Sayre, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06786078